| 000 | 01173 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513215942.0 | ||
| 264 | 0 | _c20000831 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.55.4.606 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSolomon, G E | |
| 245 | 0 | 0 |
_aValproate-induced hyperammonemic encephalopathy in the presence of topiramate. _h[electronic resource] |
| 260 |
_bNeurology _cAug 2000 |
||
| 300 |
_a606 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAmmonia _xblood |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aElectroencephalography _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFructose _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xblood |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xdrug effects |
| 650 | 0 | 4 |
_aSeizures _xdrug therapy |
| 650 | 0 | 4 | _aTopiramate |
| 650 | 0 | 4 |
_aValproic Acid _xadverse effects |
| 773 | 0 |
_tNeurology _gvol. 55 _gno. 4 _gp. 606 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.55.4.606 _zAvailable from publisher's website |
| 999 |
_c10901798 _d10901798 |
||